Sonic hedgehog signaling: Alternative splicing and pathogenic role in medulloblastoma

被引:3
|
作者
Qu, Meiyu [1 ,2 ]
He, Qiangqiang [2 ]
Luo, Jiahao [2 ]
Shen, Tingyu [2 ]
Gao, Ruibo [2 ]
Xu, Yana [2 ]
Xu, Chengyun [2 ]
Barkat, Muhammad Qasim [2 ]
Zeng, Ling-Hui [1 ]
Wu, Ximei [2 ]
机构
[1] Zhejiang Univ City Coll, Dept Pharmacol, 51 Huzhou St, Hangzhou 310015, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Dept Pharmacol, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Alternative splicing; Exon; Hedgehog signaling; Medulloblastoma; Tumor suppressor; PHYSICOCHEMICAL PROPERTIES; MOLECULAR SUBGROUPS; HISTONE DEACETYLASE; G870A POLYMORPHISM; STREPTOMYCES SP; GEX1; COMPOUNDS; BREAST-CANCER; INHIBITOR; GENE; MECHANISMS;
D O I
10.1016/j.gendis.2022.10.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alternative splicing (AS) produces the different mRNA splicing bodies, which are then translated into multiple protein isoforms and participate in various biological functions. With a deeper understanding of alternative splicing through the study of transcriptomes using high-throughput sequencing-based methods, the correlation between aberrant AS and diseases triggered a great concern, especially abnormal AS and cancer. Medulloblastoma (MB) is an intracranial tumor in children. Sonic hedgehog MB (SHH-MB) accounted for approximately 30% of MB, which is associated with the activation of SHH signaling. Growing evidence shows that aberrant AS is closely related to the tumorigenesis of MB. Here, we briefly introduced the AS and its mechanism. Next, we described canonical/noncanonical hedgehog signaling and its correlation with MB. The main description focused on AS of various regulators in canon-ical hedgehog signaling in MB. In addition, we also described AS of various regulators in nonca-nonical hedgehog signaling. Meanwhile, activated hedgehog signaling also induces AS in MB. Then, we pointed out that aberrant AS of hedgehog signaling is associated with different MB subgroups. Finally, we summarized the therapeutic applications of targeted AS in cancer treatment. In summary, further understanding of AS in SHH-MB could develop therapeutic targets for splicing factors which may be a novel therapeutic strategy.& COPY; 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:2013 / 2028
页数:16
相关论文
共 50 条
  • [41] HIF1a downstream of Sonic hedgehog mitogenic and oncogenic signaling and brain development and medulloblastoma
    Awan, Aashir
    Wolfe, Holly
    Guldal, Cemile
    Bhatia, Bobby
    Kenney, Anna M.
    CANCER RESEARCH, 2012, 72
  • [42] HIF1α DOWNSTREAM OF SONIC HEDGEHOG MITOGENIC AND ONCOGENIC SIGNALING AND BRAIN DEVELOPMENT AND MEDULLOBLASTOMA
    Potts, Chad
    Cline, Holly
    Rotenberry, Rachel
    Guldal, Cemile
    Bhatia, Bobby
    Nahle, Zaher
    Kenney, Anna
    NEURO-ONCOLOGY, 2012, 14 : 84 - 84
  • [43] Generating a mouse model for relapsed Sonic Hedgehog medulloblastoma
    Heller, Allie
    Du, Fang
    Liu, Yongqiang
    Yang, Yijun
    Yang, Zeng-Jie
    STAR PROTOCOLS, 2023, 4 (02):
  • [44] Mutations in the sonic hedgehog pathway: Enhancement of medulloblastoma induction
    Weiner, HL
    Pompeiano, M
    Mohan, A
    Turnbull, DH
    Joyner, AL
    JOURNAL OF NEUROSURGERY, 2004, 100 (04) : 780 - 780
  • [45] A simple and scalable zebrafish model of Sonic hedgehog medulloblastoma
    Casey, Mattie J.
    Chan, Priya P.
    Li, Qing
    Zu, Ju-Fen
    Jette, Cicely A.
    Kohler, Missia
    Myers, Benjamin R.
    Stewart, Rodney A.
    CELL REPORTS, 2024, 43 (08):
  • [46] Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma
    Jenkins, Noah C.
    Kalra, Ricky R.
    Dubuc, Adrian
    Sivakumar, Walavan
    Pedone, Carolyn A.
    Wu, Xiaochong
    Taylor, Michael D.
    Fults, Daniel W.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [47] Targeted treatment for sonic hedgehog-dependent medulloblastoma
    Kieran, Mark W.
    NEURO-ONCOLOGY, 2014, 16 (08) : 1037 - 1047
  • [48] Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma
    Noah C Jenkins
    Ricky R Kalra
    Adrian Dubuc
    Walavan Sivakumar
    Carolyn A Pedone
    Xiaochong Wu
    Michael D Taylor
    Daniel W Fults
    Acta Neuropathologica Communications, 2
  • [49] FORETINIB IS EFFECTIVE THERAPY FOR METASTATIC SONIC HEDGEHOG MEDULLOBLASTOMA
    Smith, Christian
    Faria, Claudia C.
    Dubuc, AdrianM.
    Remke, Marc
    Golbourn, Brian J.
    Diaz, Roberto J.
    Agnihotri, Sameer
    Luck, Amanda
    Sabha, Nesrin
    Olsen, Samantha
    Wu, Xiaochong
    Garzia, Livia
    Ramaswamy, Vijay
    Mack, Stephen C.
    Wang, Xin
    Leadley, Michael
    Reynaud, Denis
    Ermini, Leonardo
    Post, Martin
    Northcott, Paul A.
    Pfister, Stefan M.
    Croul, Sidney E.
    Kool, Marcel
    Korshunov, Andrey
    Taylor, Michael D.
    Rutka, James T.
    NEURO-ONCOLOGY, 2014, 16
  • [50] Foretinib Is Effective Therapy for Metastatic Sonic Hedgehog Medulloblastoma
    Faria, Claudia C.
    Golbourn, Brian J.
    Dubuc, Adrian M.
    Remke, Marc
    Diaz, Roberto J.
    Agnihotri, Sameer
    Luck, Amanda
    Sabha, Nesrin
    Olsen, Samantha
    Wu, Xiaochong
    Garzia, Livia
    Ramaswamy, Vijay
    Mack, Stephen C.
    Wang, Xin
    Leadley, Michael
    Reynaud, Denis
    Ermini, Leonardo
    Post, Martin
    Northcott, Paul A.
    Pfister, Stefan M.
    Croul, Sidney E.
    Kool, Marcel
    Korshunov, Andrey
    Smith, Christian A.
    Taylor, MichaelD.
    Rutka, James T.
    CANCER RESEARCH, 2015, 75 (01) : 134 - 146